The current system for pregnancy and postnatal blood clot risk assessments is inadequate and could place pregnant women/people at risk of needing follow-on treatment or potentially fatal outcomes, a ...

Please provide your email address to receive an email when new articles are posted on . Venous thromboembolism incidence was higher among those with vs. without a history of preeclampsia. Preeclampsia ...

After publication of potentially practice-changing clinical trials, identified through ASCO's signals approach to updating, an updated systematic review was performed for two guideline questions: ...

A recent Scientific Reports study investigated the association between obesity in early pregnancy and long-term post-pregnancy risk of venous thromboembolism (VTE). Study: Prepregnancy overweight and ...

Prospective and working memory decline as a result of impaired sleep and/or impared blood glucose in breast cancer patients during chemotherapy treatment. Background: VTE is a major cause of morbidity ...

Risk of VTE among different hormonal contraceptives varied by method and dose. Combined pills and injections had the highest risk. Pregnancy also carries heightened VTE risk. Among hormonal ...

Results highlighted in two oral presentations at the American Society of Hematology Annual Meeting In a second oral presentation, results from a sub-group analysis of the primary study were ...

In honor of World Thrombosis Day (WTD), a disease awareness campaign sponsored by the International Society on Thrombosis and Haemostasis (ISTH), Stago presents a special educational event. The ...

Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to ...

Rising maternal age and advanced prenatal testing contribute to increased recognition of cancer during pregnancy. Breast, hematologic, melanoma, and cervical cancers are most frequently diagnosed.

Please provide your email address to receive an email when new articles are posted on . FDA approved rivaroxaban in tablet form and as an oral suspension to treat and reduce the risk for recurrence of ...

Increased rate of major bleeding and lower mortality rates observed, resulting in greater net clinical benefit.